Donor heart preservation with a novel long-term and slow-releasing hydrogen sulfide system.

Nitric Oxide 2018 12 11;81:1-10. Epub 2018 Sep 11.

Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University, Shanghai, 200040, China. Electronic address:

Cardiac transplantation has been limited by the inability to long preserve donor hearts safely. Hydrogen sulfide (HS) has been recognized as an important gasotransmitter exerting potent cardioprotection from ischemia/reperfusion injury (I/R). Herein we investigated the cardioprotective effects of a novel long-term and slow-releasing HS system, namely DATS-MSN, in heart preservation solution using a heart transplantation models. The release of HS from DATS-MSN was slow and continuous in the University of Wisconsin solution (UW), correspondingly, DATS-MSN application demonstrated superior cardioprotective effects over the control and traditional HS donors after 6 h heart preservation and 1 h reperfusion, associated with greater allograft performance including left ventricular developed pressure (LVDP) and dP/dt , reduced plasmic CK-MB and troponin I levels, inhibited myocardial inflammation, increased antioxidant enzyme activities, preserved mitochondria structure and function, and decreased cardiomyocyte apoptosis index. Also, DATS-MSN application presented significant superiority in long-term allografts survival and function after 8 weeks of transplantation. In the in vitro experiments, cardiomyocytes injury from hypoxia was found to be relived with the treatment of DATS-MSN by anti-inflammatory effects via TLR4/NLRP3 pathway. The present work provides a long-term releasing HS donor compatibly applied in the donor heart preservation, and preliminary explores its underlying mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.niox.2018.09.001DOI Listing
December 2018
Save 15% Survey

Similar Publications

Repair, Reconstruct, or Divert: Fate of the Perforated Esophagus.

Ann Surg 2021 Jan 15. Epub 2021 Jan 15.

*Heart and Vascular Institute, Department of Thoracic and Cardiovascular Surgery, Cleveland, OH †Research Institute, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.

Objectives: The aim of this study was to determine differences in esophageal perforation populations undergoing different advanced interventions for perforated esophagus and identify predictors of treatment outcomes.

Summary Background Data: Contained esophageal perforation can often be managed expectantly, but uncontained perforation is uniformly fatal without invasive intervention. Treatment options for the latter range from simple endoscopic control through advanced intervention. Read More

View Article and Full-Text PDF
January 2021

Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury.

Cell Death Dis 2021 Feb 24;12(2):211. Epub 2021 Feb 24.

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Engineering Research Center of Natural Polymer-based Medical Materials in Hubei Province, Wuhan, China.

Ischemia-reperfusion injury (IRI) is an inevitable and serious clinical problem in donations after heart death (DCD) liver transplantation. Excessive sterile inflammation plays a fateful role in liver IRI. Hypothermic oxygenated perfusion (HOPE), as an emerging organ preservation technology, has a better preservation effect than cold storage (CS) for reducing liver IRI, in which regulating inflammation is one of the main mechanisms. Read More

View Article and Full-Text PDF
February 2021

Mesenchymal stem cell-derived conditioned medium protects vascular grafts of brain-dead rats against in vitro ischemia/reperfusion injury.

Stem Cell Res Ther 2021 Feb 24;12(1):144. Epub 2021 Feb 24.

Department of Cardiac Surgery, Laboratory of Cardiac Surgery, University Hospital Heidelberg, INF 326, 69120, Heidelberg, Germany.

Background: Brain death (BD) has been suggested to induce coronary endothelial dysfunction. Ischemia/reperfusion (IR) injury during heart transplantation may lead to further damage of the endothelium. Previous studies have shown protective effects of conditioned medium (CM) from bone marrow-derived mesenchymal stem cells (MSCs) against IR injury. Read More

View Article and Full-Text PDF
February 2021

Peritransplant Cardiometabolic and Mitochondrial Function: The Missing Piece in Donor Heart Dysfunction and Graft Failure.

Transplantation 2021 Mar;105(3):496-508

School of medical Science, Griffith University Gold Coast, Australia.

Primary graft dysfunction is an important cause of morbidity and mortality after cardiac transplantation. Donor brain stem death (BSD) is a significant contributor to donor heart dysfunction and primary graft dysfunction. There remain substantial gaps in the mechanistic understanding of peritransplant cardiac dysfunction. Read More

View Article and Full-Text PDF

Using Decellularization/Recellularization Processes to Prepare Liver and Cardiac Engineered Tissues.

Methods Mol Biol 2021 ;2273:111-129

Sohnis Research laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.

Tissue engineering provides unique opportunities for disease modeling, drug testing, and regenerative medicine applications. The use of cell-seeded scaffolds to promote tissue development is the hallmark of the tissue engineering. Among the different types of scaffolds (derived from either natural or synthetic polymers) used in the field, the use of decellularized tissues/organs is specifically attractive. Read More

View Article and Full-Text PDF
January 2021